The NeuroFit randomised controlled trial evaluated a three-month structured exercise programme against cognitive performance, mood, and markers of adult hippocampal neurogenesis in humans. The design addresses a persistent gap between animal evidence for exercise-induced neurogenesis and measurable outcomes in people. Its relevance to longevity lies in testing whether a defined training dose produces detectable changes in brain plasticity within a clinically practical timeframe.
Key Points
- Randomised trial tested three-month exercise against cognition, mood, neurogenesis markers
- Human design bridges gap from animal neurogenesis research
- Twelve weeks assessed as a practical window for brain adaptation
Longevity Analysis
Cognitive decline tracks closely with vascular health, mitochondrial capacity, and the regenerative reserve of the hippocampus, which makes structured movement one of the few interventions acting simultaneously across all three. Trials of this kind matter because they quantify dose and duration rather than leaving exercise as a general recommendation, allowing progress to be tracked against defined markers rather than subjective impressions. Mood outcomes measured alongside cognition also acknowledge that regulation of stress signalling and emotional state is inseparable from how the brain maintains and rebuilds its tissue.
Original published by Nature - npj Aging, by Sahand Farmand.